We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Cognitive-behavioral disorders affect development and behavior, especially during early childhood. Early detection, observation by parents and pediatricians, and targeted interventions based on the cause help optimize learning and minimize long-term effects.
There are two basic aspects in the prevention, detection, and treatment of cognitive-behavioral disorders: observation by the parents and observation by the child’s pediatrician. This highlights the importance of routine visits to the pediatrician.
During the first year of life, stimulation through play and singing is fundamental. The brain’s plasticity for learning during the first year is higher than at any other stage of life, and the brain’s weight grows exponentially. Stimuli are essential; both smiling and passive limb mobilization naturally occur through play. Observing the child is also important to see which areas need more work, such as teaching them to roll over, crawl, or walk. In case of doubt or detection of a significant alteration, a multidisciplinary approach is necessary to establish the diagnosis and appropriate treatment as early as possible.
The treatment of cognitive-behavioral disorders depends on the specific condition detected.
Human genome ultra-sequencing now allows the detection of hundreds of genetic alterations from a small blood sample, from which genetic information is extracted. There are databases in all developed countries that work in a network, sharing information to compile sporadic cases worldwide for joint research into how these alterations affect behavior or learning in individuals.
Similarly, biochemical studies of the body’s metabolic pathways are increasingly comprehensive, allowing the design of specific drugs for each situation.
A treatment shift currently under development involves moving from the pill to the cell, aiming to work directly on the affected cell to modify its behavior. This approach is still very preliminary but is a field that is certain to see significant development in the future.
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.